Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Neal C. Bradsher currently holds 75,000 shares of Lineage Cell Therapeutics, Inc. (LCTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Neal C. Bradsher has been a net seller of LCTX stock. They have purchased $77.2M and sold $149.0M worth of shares.
Neal C. Bradsher's most recent insider trade was on Jul 1, 2024, when they sold 75,000 shares at $0.00 per share.
Neal C. Bradsher serves as Executive at Lineage Cell Therapeutics, Inc. (LCTX). They have executed 355 insider transactions totaling $226.2M over their tenure at the company.
Neal C. Bradsher holds the position of Executive at Lineage Cell Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Neal C. Bradsher has shown a selling trading pattern, with $77.2M in total purchases and $149.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Neal C. Bradsher was on Jan 26, 2021, when they sold $35.5M worth of STAA shares. This transaction involved 347,000 shares at $102.33 per share.
Neal C. Bradsher currently owns 75,000 shares of Lineage Cell Therapeutics, Inc. (LCTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Neal C. Bradsher's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Neal C. Bradsher has 355 Form 4 filings on record as an insider at Lineage Cell Therapeutics, Inc..
Set alerts for Neal C. Bradsher and 40,000+ other insiders.